Release test results
99.675%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 5.03 mg
Related impurities (total)0.325%
Endotoxin<1.0 EU/mg
HPLC retention time9.6 min
MethodHPLC + LC-MS
ResultPass · meets spec
Lot record
CompoundSelank
Presentation5 MG
Lot numberRGX-26-SELANK-1051
COA numberNS-2026-05052
Test date13 Jul 2026
Release date16 Jul 2026
Independent labNordicstar Labs
StatusCurrent
Selank — lot history
| Lot | Presentation | Tested | HPLC purity | Status |
|---|---|---|---|---|
| RGX-26-SELANK-1051 this lot | 5 MG | Jul 13, 2026 | 99.675% | Current |
| RGX-26-SELANK-1052 | 10 MG | Jul 13, 2026 | 99.637% | Current |
| RGX-26-SELANK-748 | 10 MG | Apr 6, 2026 | 99.567% | Superseded |
| RGX-26-SELANK-749 | 5 MG | Mar 31, 2026 | 99.698% | Superseded |
| RGX-26-SELANK-649 | 5 MG | Jan 7, 2026 | 99.750% | Superseded |
| RGX-26-SELANK-648 | 10 MG | Jan 2, 2026 | 99.631% | Superseded |
!
Research use only
This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →